Excluding the impact of currency sales at Cambrex rose 2%. The company attributed the rise to the timing of orders related to two APIs manufactured under long-term supply agreements and an API that incorporates its polymeric drug delivery technology. However Cambrex said this was partially offset by lower sales of generic APIs and feed additives.
Cambrex
Wednesday 5 August 2009
Cambrex reports sales rise
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment